ImmunityBio IBRX
NASDAQ IBRX
$8.37 -0.27 (-3.13%)
As of: Oct 22, 2026 · 11:38 AM EDT

ImmunityBio (IBRX) Operating Margin (2014 - 2026)

Updated

ImmunityBio's Operating Margin came in at -120.41% for Q2 2026, up 149.36 percentage points from -269.76% a year earlier and up 37.47 percentage points from the prior quarter.

Analysis

ImmunityBio (IBRX) Operating Margin (2014 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, ImmunityBio reported Operating Margin of -151.88%, up 352.30 percentage points year-over-year; for FY2025, it came in at -226.00%, up 2108.23 percentage points from FY2024.

  • Operating Margin has increased in each of the last three years, with a five-year change of +36283.09 percentage points (FY2020 to FY2025).
  • Going back by year, Operating Margin was -2334.23% in FY2024 (+55905.32 pp), -58239.55% in FY2023 (+88134.62 pp), -146374.17% in FY2022 (-111012.28 pp) and -35361.88% in FY2021 (+1147.21 pp).
  • The Q2 2026 figure represents the highest quarterly Operating Margin in data going back to Q1 2014.
  • Year-over-year, Operating Margin has increased for nine consecutive quarters, with an average year-over-year change of +50751.80 percentage points over the last eight quarters.
  • The fastest year-over-year change in Operating Margin over five years came in Q1 2023 (a gain of 654519.84 percentage points), and the weakest in Q1 2022 (a drop of 623453.85 percentage points).
  • Business Quant data shows IBRX's Operating Margin at -157.88% (Q1 2026), -168.95% (Q4 2025) and -173.51% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,175.59 Bn 1,144.18 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 639.41 Bn 557.93 Bn 17.26 Bn 28.21%
3 AbbVie 502.56 Bn 475.67 Bn 12.70 Bn 37.86%
4 Merck 375.27 Bn 329.65 Bn 12.21 Bn -3.52%
5 Novartis Ag 303.16 Bn 267.15 Bn 11.24 Bn 32.97%
6 Astrazeneca 268.63 Bn 242.32 Bn 12.86 Bn 20.57%
7 Amgen 242.12 Bn 197.52 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.40 Bn 167.60 Bn 6.22 Bn -133.21%
9 Pfizer 172.79 Bn 119.44 Bn 10.94 Bn 28.37%
10 ImmunityBio 8.78 Bn 7.54 Bn 50.94 Mn -120.41%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -120.41%
Mar 31, 2026 -157.88%
Dec 31, 2025 -168.95%
Sep 30, 2025 -173.51%
Jun 30, 2025 -269.76%
Mar 31, 2025 -390.08%
Dec 31, 2024 -918.96%
Sep 30, 2024 -1,314.33%
Jun 30, 2024 -9,487.39%
Mar 31, 2024 -237,990.00%
Dec 31, 2023 -61,430.94%
Sep 30, 2023 -97,726.83%
Jun 30, 2023 -207,670.73%
Mar 31, 2023 -30,994.44%
Dec 31, 2022 -116,301.37%
Sep 30, 2022 -76,952.54%
Jun 30, 2022 -227,491.43%
Mar 31, 2022 -685,514.29%
Dec 31, 2021 -20,326.67%
Sep 30, 2021 -119,448.48%
API Access

ImmunityBio Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=IBRX&period=max&api_key=YOUR_API_KEY